Treviamet 50mg +1000mg x35

Treviamet Tablets is an oral blood-glucose-lowering medication containing a combination of two active ingredients: Sitagliptin (50 mg) and Metformin HCl (1000 mg). It is used to improve glycemic control in adults with type 2 diabetes mellitus. As a combination therapy, it works through two mechanisms: Sitagliptin, a DPP-4 inhibitor, increases the levels of natural substances (incretins) that help control blood sugar by increasing insulin release and decreasing the amount of sugar the liver produces. Metformin HCl further assists by improving the body’s sensitivity to insulin and reducing the amount of sugar absorbed by the intestines.

This tablet formulation is designed to be used in conjunction with a proper diet and exercise regimen to effectively manage and stabilize blood sugar levels throughout the day.

Key Benefits:

– Dual-Action Glycemic Control

– Effective Blood Sugar Management

– High-Potency Combination

– Quality Pharmaceutical Standards

– Optimal Supply Pack